SOM BIOTECH LICENSES ITS FIRST DRUG

posted on July 5, 2013

SOM has licensed to the biotech  ARGON Pharma  a new product with potential properties for the treatment of multiforme glioblastoma. The compound was discovered by SOM as SOM0777.